Literature DB >> 18301352

The UCP2-866 A/A genotype is associated with low density lipoprotein particle sizes in the general population.

Taku Hamada1, Kazuhiko Kotani, Shinji Fujiwara, Yoshiko Sano, Masayuki Domichi, Kokoro Tsuzaki, Kaoru Takahashi, Naoki Sakane.   

Abstract

BACKGROUND: It has been reported that a common G-->A single nucleotide polymorphism (SNP) at the position -866 of the uncoupling protein-2 promoter (UCP2-866 G/A SNP) modulates UCP2 expression in adipose tissue and pancreatic beta-cell function, and lipid profiles. Reduced low density lipoprotein (LDL) particle size is a significant predictor of the development for coronary artery disease. The purpose of this study was to investigate whether the UCP2-866 G/A SNP was associated with serum LDL particle characteristics in a general Japanese population. MATERIAL/
METHODS: In 279 subjects (age 65+/-13 years), body mass index (BMI), percent body fat, blood pressure, and blood biochemical profiles were measured. The UCP2-866 G/A SNP was determined with a fluorescence-based allele-specific DNA primer assay system. LDL particle characteristics were analyzed by high-resolution polyacrylamide gel electrophoresis.
RESULTS: The frequency of the -866 A allele was 47.8%. There was no difference in triglyceride, total cholesterol, LDL-cholesterol, HDL-cholesterol, and small dense LDL levels between genotypes. However, subjects with the -866 A/A genotype had significantly lower mean LDL particle size levels (263.5+/-4.9 angstroms) than those with the -866 G/G genotype (264.6+/-4.9 angstroms, P=0.034). Multiple regression analysis revealed that the -866 A/A genotype was a significant variable contributing to the variance in the reduced LDL particle size levels (P=0.012).
CONCLUSIONS: The -866 A/A genotype may contribute to reduced LDL particle size levels, a significant risk factor for the development of coronary artery disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18301352

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN: 1234-1010


  6 in total

Review 1.  UCP2, a mitochondrial protein regulated at multiple levels.

Authors:  Massimo Donadelli; Ilaria Dando; Claudia Fiorini; Marta Palmieri
Journal:  Cell Mol Life Sci       Date:  2013-06-27       Impact factor: 9.261

2.  Capsaicin supplementation fails to modulate autonomic and cardiac electrophysiologic activity during exercise in the obese: with variants of UCP2 and UCP3 polymorphism.

Authors:  Ki Ok Shin; Toshio Moritani
Journal:  J Sports Sci Med       Date:  2008-09-01       Impact factor: 2.988

3.  Uncoupling protein 2 gene polymorphisms are associated with obesity.

Authors:  Sukma Oktavianthi; Hidayat Trimarsanto; Clarissa A Febinia; Ketut Suastika; Made R Saraswati; Pande Dwipayana; Wibowo Arindrarto; Herawati Sudoyo; Safarina G Malik
Journal:  Cardiovasc Diabetol       Date:  2012-04-25       Impact factor: 9.951

4.  Common UCP2 variants contribute to serum urate concentrations and the risk of hyperuricemia.

Authors:  Luyu Yang; Zheng Dong; Jingru Zhou; Yanyun Ma; Weilin Pu; Dongbao Zhao; Hongjun He; Hengdong Ji; Yajun Yang; Xiaofeng Wang; Xia Xu; Yafei Pang; Hejian Zou; Li Jin; Chengde Yang; Jiucun Wang
Journal:  Sci Rep       Date:  2016-06-08       Impact factor: 4.379

Review 5.  Uncoupling Protein 2 in Cardiovascular Health and Disease.

Authors:  Xiao Yu Tian; Shuangtao Ma; Gary Tse; Wing Tak Wong; Yu Huang
Journal:  Front Physiol       Date:  2018-08-02       Impact factor: 4.566

6.  Meta-analysis reveals the association of common variants in the uncoupling protein (UCP) 1-3 genes with body mass index variability.

Authors:  Letícia A Brondani; Tais S Assmann; Bianca M de Souza; Ana P Bouças; Luis H Canani; Daisy Crispim
Journal:  PLoS One       Date:  2014-05-07       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.